Neurology

Headache Relief Shampoo Voted #1 Best New Product in 2019

headache relief shampoo bottles

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019Comments OffHeadache Drug Trial | Headache Relief | Headache Shampoo | Headache Study | Headache Therapy
Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

Conditions:   Stroke;   Weakness of Extremities as Sequela of Stroke
Interventions:   Device: Indego Exoskeleton;   Other: Standard Rehabilitation
Sponsor:   University of Oklahoma
Not yet recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 10, 2019Comments OffEffects | ExoskeletonAssisted | Functional | Gait | Outcomes | Patients | Rehabilitation | Stroke | Training
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis

Condition:   Multiple Sclerosis (MS)
Interventions:   Drug: Ocrelizumab;   Drug: rHuPH20
Sponsor:   Hoffmann-La Roche
Not yet recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 3, 2019Comments OffAdministration | Investigate | Multiple | Ocrelizumab | Patients | Pharmacokinetics | Safety | Sclerosis | Study | Subcutaneous | Tolerability
Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

Condition:   Generalized Myasthenia Gravis
Interventions:   Biological: Ravulizumab;   Drug: Placebo
Sponsor:   Alexion Pharmaceuticals
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 23, 2019Comments OffAdults | Efficacy | Generalized | Gravis | Myasthenia | Ravulizumab | Safety | Study
Long-term Cardiac Monitoring in Epilepsy

Conditions:   Focal Epilepsy;   Intractable Epilepsy;   Epileptic Encephalopathy;   Lennox Gastaut Syndrome;   Symptomatic Epilepsy;   Generalized Epilepsy
Intervention:   Device: Reveal LINQ ICM System
Sponsors:   Northwell Health;   Medtronic
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 20, 2019Comments OffCardiac | Epilepsy | Longterm | Monitoring
Intravenous Gene Transfer With an AAV9 Vector Expressing Human

Conditions:   Lysosomal Diseases;   Gangliosidosis;   GM1
Intervention:   Biological: AAV9-GLB1
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 17, 2019Comments OffAAV9 | Expressing | Gene | Human | Intravenous | Transfer | Vector
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas

Condition:   Low-grade Glioma
Interventions:   Device: ReMind iPad app;   Device: Healthy SMS texting;   Behavioral: In-person cognitive rehabilitation
Sponsors:   University of California, San Francisco;   University of Tilburg;   University of California, Berkeley
Not yet recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 14, 2019Comments OffAdult | Cognition | FollowUp | Gliomas | Grade | Longitudinal | Lower | Rehabilitation
Phase IV Study in Parkinson’s Disease Patients Treated With XADAGO (Safinamide)

Condition:   Idiopathic Parkinson Disease
Intervention:   Drug: XADAGO (safinamide)
Sponsor:   US WorldMeds LLC
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 11, 2019Comments OffDisease | Parkinson's | Patients | Phase | Safinamide | Study | Treated | XADAGO
Transcranial Direct Current Stimulation for Post-stroke Motor Recovery

Conditions:   Stroke, Ischemic;   Motor Activity;   Upper Extremity Paralysis
Interventions:   Device: Sham;   Device: Low dose tDCS;   Device: High dose tDCS;   Behavioral: mCIMT
Sponsors:   Medical University of South Carolina;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 10, 2019Comments OffCurrent | Direct | Motor | Poststroke | Recovery | Stimulation | Transcranial